Company Active PLC

Company profile

Redx Pharma PLC

Home - Redx

Redx Pharma PLC is a UK company with status active founded in 2010 based in North West England.

CRN
07368089
Founded
2010
Age
15

Overview

Legal name
REDX PHARMA LIMITED
Region
North West England
Registered address
BLOCK 33 MERESIDE
ALDERLEY PARK
MACCLESFIELD
ENGLAND
SK10 4TG
Insolvency history
Yes

Corporate ownership

Updated 06 Jun 2026 16:52

Redx Pharma PLC
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

10 events
21 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Jun
2026

Accounts due

Accounts Due

Next accounts due date

26 May
2026

Change To A Person With Significant Control

Persons-with-significant-control

PSC04 | Transaction MzUyMzYzMjAzM2FkaXF6a2N4

Published 26 May 2026 08:47

07 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Sep
2024

Accounts filed

Accounts

Last accounts made up date

19 Sep
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzNjQ5NjI3NmFkaXF6a2N4

Published 19 Sep 2024 08:13

14 Aug
2024

Resolution

Resolution

RESOLUTIONS | Transaction WUQ5QklMSVdhZGlxemtjeA | Paper/PDF filed

Published 15 Aug 2024 07:53

12 Aug
2024

Memorandum Articles

Incorporation

MA | Transaction MzQzMTUyOTA3OGFkaXF6a2N4 | Paper/PDF filed

Published 13 Aug 2024 07:54

08 Aug
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzMTY0NzQ4OWFkaXF6a2N4

Published 08 Aug 2024 18:18

07 Sep
2010

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2019
Funded years
2019
Age at first award
9 years

Projects

2019 Collaborative R&D Lead participant

Pre-Clinical Validation and Translation of a Novel Anti-Fibrotic

1 Oct 2019 to 31 Jan 2021

Awarded
£177,541
Total cost £377,185

Several prominent researchers in fibrosis have estimated that 1:2 deaths are caused by complications associated with fibrosis. The prototype fibrotic disease is Idiopathic Pulmonary Fibrosis (IPF): characterised by altered lung architecture and loss of respiratory surface area leading to increased deposition of extracellular matrix in the lung interstitiu...

Product types

Collaborative R&D